Wan-Shan Chen
CIK 2001438 · last filed 2026-10-30
Wan-Shan Chen is a corporate insider who has filed 10 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing shows the insider exercised options on $6.1K of BLTE on Oct 30, 2026. Across all open-market trades the lifetime net is −$198.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.7M across reported positions. 7 Form 144 notices of planned sales are also on file; the latest, for Belite Bio, Inc on Apr 9, 2026, lists the filer as an affiliate. 12 sales listed on those notices, worth $466.5K in all, have no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLTE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLTE | Director | 37,259 | $152.72 | $5.69M | -$198.5K | 3 | 2026-10-30 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-30 | BLTE | Exer (X) | +13,796 | $6.1K | EDGAR |
| 2026-04-13 | BLTE | Sell (S)10b5-1 Plan adopted Dec 23, 2025 |
−1,100 | -$198.5K | EDGAR |
| 2026-04-09 | Belite Bio, Inc | Notice (144) Affiliate · Planned Apr 9, 2026 No sale on file |
−10,196 | -$2.22M | EDGAR |
| 2026-04-02 | BLTE | Grant (A) | — | $0 | EDGAR |
| 2025-10-17 | Belite Bio, Inc | Notice (144) Affiliate · Planned Oct 17, 2025 No sale on file |
−9,550 | -$1.16M | EDGAR |
| 2025-10-16 | Belite Bio, Inc | Notice (144) Affiliate · Planned Oct 16, 2025 Sold: listed on the Oct 17, 2025 notice |
−1,050 | -$89.2K | EDGAR |
| 2025-10-14 | Belite Bio, Inc | Notice (144) Affiliate · Planned Oct 13, 2025 · 10b5-1 plan Sold: listed on the Oct 16, 2025 notice |
−1,050 | -$84.0K | EDGAR |
| 2024-09-04 | Belite Bio, Inc | Notice (144) Affiliate · Planned Sep 4, 2024 No sale on file |
−6,650 | -$319.9K | EDGAR |
| 2024-03-22 | Belite Bio, Inc | Notice (144) Affiliate · Planned Mar 22, 2024 Sold: listed on the Sep 4, 2024 notice |
−10,000 | -$42.6K | EDGAR |
| 2023-11-28 | Belite Bio Inc | Notice (144) Affiliate · Planned Nov 28, 2023 Sold: listed on the Mar 22, 2024 notice |
−6,000 | -$224.9K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
12 sales · $466.5K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2025-10-16 | Belite Bio, Inc | 1,050 | $89.2K | $85.00 | 2025-10-17 |
| 2025-10-13 | Belite Bio, Inc | 1,050 | $84.0K | $80.00 | 2025-10-16 |
| 2024-06-20 | Belite Bio, Inc | 500 | $24.5K | $49.08 | 2024-09-04 |
| 2024-06-18 | Belite Bio, Inc | 300 | $14.9K | $49.63 | 2024-09-04 |
| 2024-06-17 | Belite Bio, Inc | 900 | $44.5K | $49.48 | 2024-09-04 |
| 2024-06-14 | Belite Bio, Inc | 850 | $42.5K | $49.94 | 2024-09-04 |
| 2024-06-13 | Belite Bio, Inc | 250 | $12.5K | $50.10 | 2024-09-04 |
| 2024-06-12 | Belite Bio, Inc | 1,300 | $64.5K | $49.59 | 2024-09-04 |
| 2024-06-10 | Belite Bio, Inc | 550 | $26.8K | $48.77 | 2024-09-04 |
| 2024-05-30 | Belite Bio, Inc | 550 | $26.6K | $48.45 | 2024-09-04 |
| 2023-12-27 | Belite Bio, Inc | 400 | $18.3K | $45.80 | 2024-03-22 |
| 2023-12-22 | Belite Bio, Inc | 400 | $18.1K | $45.20 | 2024-03-22 |